(Q39013963)

English

Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials

scientific article published on 26 October 2016

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

0 references

Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

0 references

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

bipolar depression

1 reference

based on heuristic

inferred from title

Alexander McGirr

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28100425%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Paul A. Vöhringer

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28100425%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28100425%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

S Nassir Ghaemi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28100425%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Lakshmi N Yatham

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28100425%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

26 October 2016

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

The Lancet Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28100425%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28100425%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28100425%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1138-1146

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28100425%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Psychosocial disability and work role function compared across the long-term course of bipolar I, bipolar II and unipolar major depressive disorders

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD).

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The risk of switch to mania in patients with bipolar disorder during treatment with an antidepressant alone and in combination with a mood stabilizer

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

International prescribing patterns for mood illness: the International Mood Network (IMN).

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Antidepressants for bipolar depression: a systematic review of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Overview of antidepressant treatment of bipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of adjunctive antidepressant treatment for bipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Tranylcypromine versus imipramine in anergic bipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A clinical monitoring form for mood disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Interpretation of random effects meta-analyses.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Risperidone and paroxetine given singly and in combination for bipolar depression.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Agomelatine or placebo as adjunctive therapy to a mood stabiliser in bipolar I depression: randomised double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-regression analysis of placebo response in antipsychotic trials, 1970-2010.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Two 6-week, randomized, double-blind, placebo-controlled studies of ziprasidone in outpatients with bipolar I depression: did baseline characteristics impact trial outcome?

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

An 8-Week Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar I Depression

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Do we need to flick the switch? The need for a broader conceptualization of iatrogenic course aggravation in clinical trials of bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2816%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S2215-0366(16)30264-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28100425%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28100425%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39013963&oldid=1802402867"